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Abstract
Degradable magnesium alloys are promising biomaterials for orthopedic applications. The aim of this study was to
evaluate the potential effects on both the synovial membrane (synovialis) and the synovial fluid (synovia) of the degrad-
ation products of a MgYREZr-pin implanted in the intercondylar femoral notch in a rabbit model. Thirty-six animals were
randomized into two groups (MgYREZr or Ti6Al4V alloy) of 18 animals each. Each group was then divided into three
subgroups with implantation periods of 1, 4, and 12 weeks, with six animals in each subgroup. The initial inflammatory
reaction caused by the surgical trauma declined after 12 weeks of implantation, and elucidated a progressive recovery of
the synovial membrane. Compared with control Ti6Al4V pins, there were no significant differences between the groups.
However, after 12 weeks, recovery of the synovial membrane was more advanced in the titanium group, in which 92%
showed no signs of synovitis, than in the magnesium group. A cytotoxicity test with L929 cells and human osteoblasts
(HOB) was also conducted, according to EN ISO 10993-5/12, and no toxic leachable products were observed after 24 h
of incubation. In conclusion, the MgYREZr alloy seems to be a suitable material for intra-articular degradable implants.
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Introduction
Surgical reconstruction of the anterior cruciate liga-
ment (ACL) is a common orthopedic procedure.1
Interference screws made of metal, such as stainless
steel or titanium, are often used for the ﬁxation of the
ACL. However, biodegradable implants may be prefer-
able in order to avoid follow-up surgery for implant
removal. Degradable screws manufactured of polymers
such as poly-L-lactide or poly-DL-lactide-co-glycolide
have been used clinically, but have displayed insuﬃ-
cient mechanical stability and the degradation products
can produce adverse eﬀects.2 Intraoperative and post-
operative implant breakages of a resorbable polylactid
acid screw have been reported,3,4 as well as implant
displacement into the joint,5,6 joint swelling,7 and
tunnel widening around the implant.8
In recent years, magnesium alloys have been inves-
tigated intensively as an alternative biodegradable
material for orthopedic implants.9 Magnesium is the
fourth most common cation in the human body,10
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and it is essential for many aspects of human
physiology.11,12 The normal adult human body con-
tains approximately 21–28 g of magnesium.13 The
majority is located in bones (60–65%), and only a
small amount (1–2%) is present in the human blood
plasma.12 The magnesium serum concentration of
0.65–1.05mmol/l is regulated by the kidneys.13 About
70–80% of the magnesium appears in its cationic form
(Mg2þ), 20–30% is associated with proteins, and the
remainder is complexed with anions.13
From a technical point of view, magnesium possesses
favorable mechanical properties (elastic modulus 41–
45GPa and compressive yield strength 65–100MPa)
that are close to those of natural cortical bone and
thus reduce the risk of undesirable stress-shielding phe-
nomena.14,15 The most commonly used alloy elements
are calcium, lithium, zinc, zirconium, aluminum, and
rare earth elements (REE).9 According to DIN EN
1753, the magnesium alloy used in this study consists
of MgYREZr, and is based on the alloy WE43.
MgYREZr has showed good biological responses in
both animal16 and clinical17 studies. With respect to
WE43, several studies have reported osteoconductive
bioactivity.18,19 REE improve corrosion resistance and
strength by solid solution strengthening and precipita-
tion strengthening.20 Zirconium is typically used as a
grain reﬁnement agent in magnesium alloys, and con-
tributes to strengthening.20
Magnesium and its alloys degrade continuously in
body ﬂuids, releasing Mg2þ ions and its alloying elem-
ents into the blood and the surrounding tissues.
Chelated REE are excreted via the kidney.21 Little is
known about the eﬀects of the corrosion products of a
degradable magnesium interference screw on the syn-
ovial membrane (synovialis) and the synovial ﬂuid
(synovia). In the present study, the eﬀects of released
ions and degradation products during the corrosion
process were evaluated (i) in vitro with L929 and
HOB cells, in accordance with EN ISO 10993-5/12;
and (ii) in vivo with regard to the synovial membrane
and ﬂuid, using a magnesium alloy implant in the inter-
condylar femoral notch of the stiﬂe joint of rabbits.
Materials and methods
Study design
The animal experiments were conducted under a proto-
col approved by the local ethics committee, in accord-
ance with German federal animal welfare legislation
(Approval No. 33.9-42502-04-12/0976) and with the
National Institutes of Health Guide for the Care and
Use of Laboratory Animals. We used 36 female
New Zealand White rabbits (Charles River, Bad
Kissingen, Germany), aged 6 months old, with a
mean ( SD) body weight of 3.8 0.2 kg, which were
randomized into two implant groups of 18 animals
each. We used MgYREZr pins in the ﬁrst group, and
identically constructed titanium (Ti6Al4V) pins in the
second group. Each group was subdivided into three
subgroups, with implantation periods of 1, 4, and 12
weeks, with six animals in each subgroup. Blood sam-
ples were taken before surgery and at the end of the
implantation periods to monitor possible inﬂuences of
the corrosion products on the blood composition. The
evaluation focused on the blood values of the liver and
kidneys, and the concentration of magnesium in the
serum. Blood samples were analyzed by a certiﬁed vet-
erinary diagnostic laboratory (Laboklin, Bad
Kissingen, Germany).
Implants
The pins (MgYREZr and Ti6Al4V) were produced by
the Institute of Production Engineering and Machine
Tools (IFW) of the Leibniz Universita¨t Hannover. The
implants had a total length of 9mm and an external
diameter of 2mm and were cannulated with a diameter
of 1mm. The magnesium alloy implants were made of a
metallurgically processed magnesium alloy powder.
This aluminum-free material (MgYREZr according to
DIN EN 1753) is similar to WE43, and contains more
than 90wt% magnesium by weight. With an average
grain size of less than 5 mm, this high-performance alloy
exhibits an oﬀset elastic limit of Rp 0.2> 250MPa, a
tensile strength of >275MPa, and elongation at break
of more than 10%. The samples were sterilized prior to
testing by gamma irradiation, using 25 kGy of cobalt-
60-g radiation (BBF, Sterilization Services, Kernen,
Germany).
Surgical method
Surgery was performed under general anesthesia,
induced by intramuscular injection with ketamine
(25mg/kg; Ketanest; Albrecht, Aulendorf, Germany)
and midazolam (5mg/animal; Dormicum; CuraMED
Pharma, Karlsruhe, Germany) and a subcutaneous dose
of glycopyrroniumbromid (0.1mg/animal; Robinul,
Riemser Arzneimittel, Greifswald – Insel Riems,
Germany). For analgesia, the rabbits were given melox-
icam orally (0.15mg/kg; Metacam; Boehringer
Ingelheim, Germany) one day preoperatively, immedi-
ately preoperatively, and for the following two days.
Additionally, they received preoperative buprenorphine
subcutaneously (0.15mg/animal; Temgesic; Essex
Pharma, Mu¨nchen, Germany). To perform the endotra-
cheal intubation, each animal received an intravenous
injection with propofol (initial 1mg/kg; Propofol-
Lipuro 1%; B. Braun Melsungen, Germany).
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Following the endotracheal intubation, anesthesia was
maintained by isoﬂurane (1.5–2.5% isoﬂurane by
volume; Isoﬂuran CP; CP-Pharma, Burgdorf, Germany)
delivered in oxygen with ﬂow rate of 1.0 l/min. Infusion
of Ringer´s lactate solution (10ml/kg/h) during the entire
surgery ensured cardiovascular function.
In the left stiﬂe joint, a medial parapatellar arthrot-
omy was performed to gain access to the femoral notch.
Avoiding the cruciate ligaments, a drill hole with a diam-
eter of 2mm and a length of 8.8mm was created with a
hand-operated drill. The pins (magnesium in 18 animals;
titanium in 18 animals) were inserted into the drill hole
(Figure 1). The joint capsule, muscles, subcutis, and
cutis were closed separately using absorbable suture
material (Vicryl5-0; Ethicon, Norderstedt, Germany).
At the end of the investigation period, all animals
were anaesthetized with ketamine (25mg/kg) and mid-
azolam (5mg/animal), and euthanized by an intraven-
ous overdose of pentobarbital (release ad us. vet.;
WDT, Garbsen, Germany).
Postoperative treatment and radiological evaluation
Postoperatively, the rabbits were allowed to move unre-
stricted in their cages, and they were observed daily for
general condition, possible gas cavities, inﬂammation,
joint eﬀusion, or lameness. Antibiotic medication was
given before surgery, and continued for four more days
(enroﬂoxacin 10mg/kg orally once daily; Baytril 2.5%
Bayer Animal Health, Leverkusen, Germany).
Radiographs (anterior–posterior and lateral view)
were taken immediately after surgery and after euthan-
asia to verify implant position and to detect possible
formation of gas cavities.
Histology of the synovial membrane
After the implantation periods of 1, 4, and 12 weeks,
the rabbits were euthanized. The synovial membranes
were harvested at the medial and lateral locations of the
joint and ﬁxed in 3.5% commercial formalin. Using
standard procedures, the samples were then dehydrated
in an increasing series of alcohol and embedded in par-
aﬃn wax using an automated embedding system to
assure optimal quality. Using an SM 2000 R microtome
(Leica Biosystems, Nußloch, Germany), 1 mm thick sec-
tions were cut and mounted onto glass slides
(Engelbrecht Medizin und Labortechnik, Edermu¨nde,
Germany). The sections were stained with haematoxy-
lin and eosin (H&E) according to established protocols.
Histology of the synovial fluid
The synovial ﬂuid was processed for sectioning using a
special method established by the Institute of
Pathology of the University of Veterinary Medicine
Hannover Foundation. Brieﬂy, samples of the synovial
ﬂuid from both stiﬂe joints of each euthanized rabbit
were collected by arthrocentesis. The samples were
transferred into plastic tubes containing a ﬁxation solu-
tion of 5% glutaraldedyde and 1% sodium cacodylate.
The tubes were then centrifuged for 15min at
15,000 rpm using a Universal 2 S centrifuge (Hettich,
Tuttlingen, Germany). Using a Pasteur pipette, the pel-
lets were harvested, transferred into 0.5ml eppendorf
cups, and washed three times for 5min each in sodium
cacodylate buﬀer. After each wash, the pellets were
centrifuged for 5min at 1500 rpm. The pellets were
post-ﬁxed in a solution of 1% osmium tetroxide
(Science Services, Mu¨nchen, Germany) in sodium caco-
dylate buﬀer, and then washed and centrifuged again
three times in cacodylate buﬀer. Finally, the buﬀer was
removed with a Pasteur pipette and the pellets were
carefully overlain with liquid 3% Bacto Agar (BD
Becton Dickinson, Heidelberg, Germany) which was
heated to 100C prior to use. Using a ﬁne needle, the
pellets and the Bacto Agar were carefully stirred. The
tubes were incubated for 15min in a water bath at
Figure 1. Picture of implantation site. The MgYREZr and Ti6Al4V pins were implanted into the intercondylar femoral notch of
rabbits.
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80C, and then for 5min in a freezer at 20C. The
pellets were then carefully cut out of the tubes and
transferred into standard biopsy-processing embedding
cassettes lined with a ﬁlter paper. The samples were
then dehydrated and embedded in paraﬃn wax using
standard procedures. Using a Leica SM 2000R micro-
tome, 3–5 mm thick sections were cut and mounted onto
glass. The sections were stained with H&E using estab-
lished protocols.
Histological evaluation of the synovitis score
The histological evaluation of the synovial ﬂuid and
synovial membrane was determined using a semiquan-
titative score described by Krenn.22 For each animal,
two samples of the synovial membrane were evaluated.
The following morphological parameters of synovitis
were selected for evaluation of the synovial membrane
(Table 1):
(1) Hyperplasia of synovial lining layer;
(2) Activation of synovial stroma and
(3) Inﬂammatory inﬁltration.
Based on the change in the manifestation of each par-
ameter (absent, slight, moderate, or strong), each
parameter was scored in each sample, and the score
of all parameters was summed to give a ﬁnal score
(Figure 2; Table 1) indicating the grade of synovitis
(Table 2).
The photomicrographs of the synovial membrane
sections were taken with an Axioskop 40 microscope
combined with an AxioCam Mrc digital camera and
AxioVision software (all Zeiss, Oberkochen, Germany).
Evaluation of the synovial ﬂuid samples was con-
ducted by the Department of Pathology, University of
Veterinary Medicine, Hannover. The samples were
assessed using a semiquantitative score (Figure 3;
Table 3) developed by the aforementioned institute.
The cells were counted in each sample per visual ﬁeld
at 400 magniﬁcation at three diﬀerent locations. The
distribution of cells in the sample is inhomogeneous due
to the speciﬁc method of sample preparation. The mean
value of each sample was determined and classiﬁed
according to the semiquantitative score (Table 3).
Preparation of MgYREZr extracts for cytotoxicity
assay
MgYREZr extracts were prepared in accordance with
EN ISO 10993-5/12. The magnesium alloy samples
were immersed under cell culture conditions for 24 h
Table 1. Histopathological score of synovitis according to Krenn et al.22 for evaluation of synovial membrane (synovalis).
Evaluated parameter Score
(A) Hyperplasia / enlargement of synovial lining cell layer
- Absent 0
- Slight enlargement (two or three cell layers); giant cells are very rare 1
- Moderate enlargement (four to five cell layers); some giant cells or lymphocytes 2
- Strong enlargement (more than six cell layers); giant cells; lymphocyes are frequent 3
(B) Inflammatory infiltration
- Absent 0
- Slight inflammatory infiltration (diffusely locate single cells and small perivascular aggregates of
lymphocytes and/or plasma cells)
1
- Moderate inflammatory infiltration (perivascular and/or superficial lymphatic aggregates; small
lymphatic follicles without germinal center may be observed)
2
- Strong inflammatory infiltration (lymphatic follicles with germinal center and/or confluent
subsynovial lymphatic infiltration)
3
(C) Activation of synovial stroma/pannus formation
- Absent 0
- Slightly synovial stroma activation (low cellularity with slight edem; slight fibrosis with some
fibroblasts; no giant cells)
1
- Moderate synovial stroma activation (moderate cellularity with a moderate density of fibro-
blasts and endothelial cells; giant cells may be detected)
2
- Strong synovial stroma activation (high cellularity with dense distribution of fibroblasts and
endothelial cells; giant cells are abundant)
3
Maximum possible score for grading 9
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with a ratio of surface area to extraction medium
volume of 1.25 cm2/ml. High-density polyethylene ﬁlm
was used as a negative control (=100% viability), and a
polyurethane ﬁlm (zinc diethyldithiocarbamate) was
used as a cytotoxic reference material (positive control)
(both from Hatano Research Institute/Food and Drug
Safety Center, Ochiai Hadano, Japan) with a ratio of
surface area to extraction volume of 1.25 cm2/ml. The
extracts were ﬁltered (pore size 0.22 mm) and the pH
value and osmolality were then measured (Semi-
Micro Osmometer A0800, Knauer, Berlin, Germany).
Evaluation of cell viability of MgYREZr extracts
Mouse ﬁbrosarcoma cells L929 were obtained from the
Leibniz Institute DSMZ – German Collection of
Microorganisms and Cell Cultures (Braunschweig,
Germany). The cells were cultured in RPMI 1640
medium (Gibco/Life Technologies, Darmstadt,
Germany) plus 10% virus- and mycoplasma-free fetal
bovine serum (PAN-Biotech, Aidenbach, Germany),
and 1% CellCultureGuard (AppliChem, Darmstadt,
Germany) using standard cell culture conditions
(902% humidity, 37 1C, 5% CO2, and 20% O2).
Human primary osteoblasts (HOB; Promocell,
Heidelberg, Germany) were cultured in HOB Growth
Medium (Promocell, Heidelberg, Germany) supple-
mented with 1% CellCultureGuard (AppliChem)
under standard cell culture conditions and in accord-
ance with the manufacturer’s recommendations.
L929 cells were seeded into 96-well culture plates at a
density of 1.5 104 cells/ml. HOB cells were seeded at a
density of 3.9 104 cells/ml (0.2 ml/well). The cells were
pre-cultivated for 24 h, and then the complete medium
was replaced by the sample extracts and the cells incu-
bated for another 24 h. The test was performed in eight-
fold parallel measurement. The viability of the cells was
tested using an MTS assay (CellTiter 96 Aqueous One
Solution Cell Proliferation Assay; Promega,Mannheim,
Germany). Immediately before the test, the extracts were
replaced with cell culture medium because tetrazolium
salts interfere withmagnesium.23 The extracts were incu-
bated with the MTS salts for 2–3 h. The soluble forma-
zan product was quantiﬁed bymeasuring the absorbance
using a mQuant Microplate Spectrophotometer (BioTek
Instruments, Bad Friedrichshall, Germany) at a wave-
length of 490nm (reference wavelength 650nm). In
accordance with DIN EN ISO 10993-5, relative meta-
bolic activity below 70% was regarded as cytotoxic.
Figure 2. Hematoxylin and eosin staining of synovial membrane in its physiological conditions (a–c). The synovial lining cell layer
consists physiologically of 1–2 cell layers (a), and these can increase up to 3–5 layers in manifest synovitis (d,g). Slight inflammatory
infiltration is classified as a score of 1 (e), and there is slight stroma activation with no giant cells (f).
Table 2. Classification of synovitis grade according to Krenn
et al.22 for evaluation of synovial membrane (synovalis).
Total score Inflammatory grade Evaluation
0–1 0 No synovitis
2–3 1 Slight synovitis
4–6 2 Moderate synovitis
7–9 3 Strong synovitis
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Statistical analysis
Statistical analysis was performed with the SPSS 20.0
software package (SPSS Inc., Chicago, IL, USA). Non-
parametrical tests (Mann–Whitney U-test) were calcu-
lated to determine the diﬀerences between the implant
groups (Mg and Ti). The Kruskal–Wallis test was cal-
culated within the implant groups to determine signiﬁ-
cant diﬀerences between the implantation periods (1, 4,
and 12 weeks). If there were signiﬁcant diﬀerences, a
Mann–Whitney U-test was then performed. Statistical
analysis of the blood values was performed using a
t-test with a signiﬁcance level of p< 0.05.
Results
Clinical observation of MgYREZr implants in vivo
Clinically, all implants were well tolerated without any
signs of inﬂammation, lameness, or evidence of sub-
cutaneous gas cavities. The radiological outcome
showed no excessive gas formation and no alterations
of the bone structure (Figure 4). There were no signiﬁ-
cant diﬀerences in the blood values between the groups.
The values of magnesium, creatinine, glutamic pyruvic
transaminase (GPT), glutamic oxaloacetic transamin-
ase (GOT), and white blood cell count (WBC) in the
serum were not increased compared with normal levels.
The serum levels of urea showed elevated concentra-
tions before implantation and no further increases
after implantation in both groups (Ti6Al4V and mag-
nesium alloy).
Moderate initial synovitis and progressive recovery of
the synovial membrane after 12 weeks
The synovial membrane showed mild inﬂammatory
reactions after one and four weeks in both groups,
without signiﬁcant diﬀerences. Slight synovitis was
seen one week after surgery in 75% of the rabbits in
the magnesium group and 83% in the titanium group.
After four weeks, about 8% of the samples showed
evidence of moderate synovitis (score 2) in both the
magnesium and titanium groups. At the end of the
implantation period (12 weeks), there was no longer
any evidence of moderate synovitis, and the main
parts of the samples were assessed with score 0
(Figure 5). Diﬀerences between the magnesium and
titanium groups after 12 weeks were not statistically
signiﬁcant. During the entire implantation period,
there was no evidence of high-grade synovitis (score 3).
No high-grade synovitis evaluated in the synovial fluid
(synovia) after MgYREZr implantation
One week after surgery, the magnesium and titanium
groups both showed a synovitis score of 0–2 (Figure 6).
Only one animal in the titanium group displayed high-
grade synovitis (score 3). Four weeks after implant-
ation, the titanium group showed either no synovitis
or only slight synovitis, whereas in the magnesium
group, a moderate synovitis was observed in 33% of
the animals. Twelve weeks after implantation, either
slight synovitis or no synovitis was found in all animals
of both groups. There were no signiﬁcant diﬀerences
between the groups.
Cytotoxicity assay revealed no toxic leachable
products of MgYREZr
The relative metabolic activity of HOB and L929 cells
incubated with 100% extract were slightly decreased
compared with the non-toxic negative control
Figure 3. Hematoxylin and eosin staining of the synovial fluid. The synovitis of the synovial fluid was classified according to the
number of cells (macrophage and cells type A) in each sample. The cells were counted in each sample per visual field at 400
magnification at three different locations. The distribution of cells in the sample is inhomogeneous due to the specific method of
sample preparation.
Table 3. Semi-quantitative score for evaluation of histological
synovial fluid (synovia).
Number of cells
(macrophages or synovial
cells type A) Grade of synovitis Score
<2 No synovitis 0
2–5 Slight synovitis 1
6–10 Moderate synovitis 2
>10 Strong synovitis 3
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Figure 5. Histological evaluation of the synovial membrane
(synovialis) according to Krenn’s scoring system. After four
weeks, there was some evidence of moderate synovitis (score 2)
in both the magnesium alloy (black bars) and titanium (white
bars) groups. The moderate initial synovitis regressed after 12
weeks in both groups.
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Figure 6. The synovial fluid (synovia) was evaluated by quanti-
fication of cells (macrophages or Type A synovial cells). The grade
of synovitis decreases with implantation time in both the mag-
nesium alloy (black bar) and titanium (white bar) groups. At 12
weeks after implantation, there was slight or no synovitis in both
groups.
Figure 4. Radiographs of the implant in the femoral notch. The implant is marked by a red arrow, the evolved gas during degradation
by white arrows, and the gas cavities by a dashed line. (a) Some gas was released at the upper part of the implant and accumulated in
the medullary cavity. A small amount of gas was observed in direct contact with the implant. (b) The accumulation of gas was most
pronounced after four weeks, and (c) was decreased after 12 weeks mainly due to diffusion processes and transported by the vascular
system.
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(Figure 7). The viability rates of both cell types were
above 70%. The viability rate of the cytotoxic reference
material was reduced to 0% in both setups.
The pH value of the 100% extract in the HOB
medium was slightly increased compared with the
aged growth medium. In RPMI 1640þ 10% FBS
medium after 24 h of extraction, the pH value was
nearly unchanged. In both media, the osmolality was
decreased in the 100% extract compared with aged
growth media (Figure 8).
Discussion
In this study, we investigated the eﬀects of the degrad-
ation products of a speciﬁc magnesium alloy
(MgYREZr) on the synovial membrane and the syn-
ovial ﬂuid in a rabbit model in vivo, and on cell viability
in an in vitro assay. As a control material, a commonly
used titanium alloy (Ti6Al4V) was used, which is
known for its good biocompatibility.24 The cannulated
pin was implanted in the femoral ‘‘notch,’’ protruding
1mm so that the degradation ions had access to the
joint without disturbing the joint function.
We hypothesized that the initial inﬂammatory reac-
tion after drill surgery would decrease, followed by suc-
cessive recovery of the synovial membrane without the
appearance of severe inﬂammatory, foreign-body, or
hypersensitivity reactions. The synovial membrane
was histologically examined, and then rated using the
validated, semiquantitative score of Krenn et al.,22
which has shown a clear system of uniform diagnosis
in other studies.25,26 One of the most common histo-
logical ﬁndings in inﬂammatory reactions of the syn-
ovial membrane is hyperplasia of the synovial lining
cells.27,28 The synovial lining cell layer consists physio-
logically of 1–2 cell layers, but in manifest synovitis,
there can be 3–5 cell layers.27,29 In our study, an
enlarged lining cell layer in both groups was found.
The synovitis was most pronounced after four weeks,
and the grade of synovitis was decreased after 12 weeks.
This recovery of the synovial membrane was clearer in
the titanium group, with 92% showing no signs of
synovitis after 12 weeks. The slower recovery of the
synovial membranes in the magnesium group can be
explained by the progressive degradation and release
of corrosion products. The obvious hyperplasia of the
lining cell layer (4–5 cell layers) in the early postopera-
tive period has been described by other authors.30 This
hyperplasia decreased over the observation period, and
a full recovery to physiological conditions was observed
after around 30 days.27,30 In the present study, inﬂam-
matory reactions were still present after 30 days, which
is consistent with the ﬁndings of Nio et al.,29 who
induced a post-traumatic synovitis by cutting the
ACL. A study by Huebner et al. reported hyperplasia
of the lining cell layer and defects in cartilage 9 and 52
weeks after drilling a hole in the femoral notch without
using an implant.31 Those ﬁndings show that the opera-
tive trauma alone, without any implantation, leads to
hyperplasia of the lining cell layer of the synovial
membrane.
In addition to the histological evaluation of the syn-
ovial membrane, examination of the synovial ﬂuid was
performed, revealing signs of a chronic proliferative
synovitis, and supporting the results of the synovial
membrane examination, without signiﬁcant diﬀerences
between the groups. These ﬁndings show that the par-
ticles released during the degradation process of the
magnesium alloy did not lead to any negative reactions
in the synovial membrane, such as severe inﬂammation
or foreign body reactions. No signiﬁcant diﬀerences
were found between the two groups, and regeneration
of the synovial membrane was seen after 12 weeks.
Several studies have reported that non-degradable
metallic implants, such as Ti6Al4V, lead to release of
abrasive particles and ions from the base material.32,33
These may induce hypersensitivity reactions by activa-
tion of the immune system,32,34 and may potentially
cause numerous local and systemic negative eﬀects,
such as inﬂammation, infection, pain, eﬀusion, urti-
caria, or wound healing disorder.35,36 During the
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Figure 7. Relative metabolic activity of (a) human osteoblast
(HOB) cells and (b) L929 cells after 24 h of incubation with
extracts determined by MTS assay, shown as a box and whisker
plot (n¼8). After exposure to 100% extract, both cell types
displayed a relative metabolic activity above 70%, which is con-
sidered non-cytotoxic. High-density polyethylene film was used
as a negative control (= 100% viability) and a polyurethane film
was used as a cytotoxic positive reference material.
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degradation process of magnesium alloys, several deg-
radation products are released,37–39 and may lead to the
aforementioned inﬂammatory reactions. During the
present study, the animals had no signs of insuﬃcient
wound healing or hypersensitivity reactions. These ﬁnd-
ings agree with those of Witte et al., who compared
four diﬀerent magnesium alloys (AZ31, AZ91, WE43,
LAE442) with titanium (Ti6Al4V) and polymer (SR-
PLA96).40 No hypersensitivity reactions were described
for any of the groups.40
Several studies have described foreign-body reac-
tions and synovitis after implantation of degradable
polymer implants in ACL reconstructive surgery.41–44
Barfod et al. and Fride´n et al. described severe syn-
ovial reactions after intra-articular use of polyglycolide
implants and of lactide–glycolide copolymer
implants.41,42 A possible explanation for these reactions
is that polymer particles attach to the synovial mem-
brane and cause foreign-body reactions.45 However,
these reactions were also observed in the implantation
of non-degradable, synthetic implants in ACL recon-
structive surgery.46–48 Several histological studies have
detected phagocytes and multinucleated giant cells sur-
rounding polymer particles.43,49 Of the 71 samples in
the present study, seven (four titanium and three mag-
nesium) had foreign body granulomas visible by the
histological examination of the synovial membrane.
We speculate that these were caused by the absorbable
suture material and not by the degradation products of
the magnesium alloy. Periarticular swelling in the lat-
eral and dorsal parts of the knee were observed in four
rabbits (two with titanium implants and two with
magnesium implants), which decreased a few days
after operation. No correlation between swelling and
group (i.e. implant type) or time of implantation was
found. This phenomenon has also been described by
other authors.50
The indirect-cytotoxicity test is commonly applied to
investigate the release of potential toxic particles of
materials for medical applications in vitro. The released
ions and degradation products from the magnesium
alloy MgYREZr in the present study were non-toxic
to L929 cells and HOB after 24 h of extract prepar-
ation. This test is valuable for initial screening of dif-
ferent materials prior to in vivo testing. Degradation
rates in vitro diﬀer from those found in in vivo stu-
dies.39,51 Faster degradation rates of the material
under in vitro conditions may lead to accumulation of
various ions above toxic concentrations. In comparison
with other tested magnesium alloys, MgY4 and RS66
reduced the cell viability in the 100% extract to under
70%.51,52 On the contrary, a previous study
showed that the cell viability of osteoblasts was not
reduced below 70% for a Mg-10Dy alloy.53 The
reduced relative metabolic activity of the Mg-10Dy
alloy may be attributable to an increased Mg2þ content
in the extract.53
In vitro experiments have shown increases in pH
values during degradation of magnesium alloys because
of the production of OH.9 The optimal pH of HOB is
within the range of 7.0–7.6.54 High pH values may have
a negative eﬀect on cell viability. In addition, solutions
with high osmolality, due to high content of dissolved
ions, may inhibit cell proliferation.55 In the current
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Figure 8. Osmolality and pH value of the MgYREZr extracts after 24 h of incubation in (a) Human Osteoblast Growth (HOB)
Medium) and (b) RPMI 1640 plus 10% fetal bovine serum (FBS). The osmolalitity was decreased in both media compared with aged
growth medium. The pH value of the 100% extract of the HOB medium was increased.
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study, there was no marked change in either of these
parameters in the in vitro extracts, and we therefore
deduce that their inﬂuence on cell viability is minimal.
The magnesium alloy used in the present study con-
tains an amount of REE besides zirconium. REE are
often used in magnesium alloys to improve their mech-
anical (i.e. elasticity and ductility) and corrosive prop-
erties.56 Numerous studies have shown good
biocompatibility of alloys containing such REE.16,19,57
The magnesium alloy (MgYREZr) used in the present
study has a similar composition to WE43, which has
shown good biocompatibility, adequate corrosive char-
acteristics, and slight eﬀects on blood composition.16,18
Waizy et al. showed that the alloy used in this study
had no negative eﬀects on blood composition, and no
pathological eﬀects on the liver and the kidneys.16
Two recent in vivo studies reported the formation of
gas cavities during the degradation of magnesium
alloys.58,59 These accumulations of gas have been
shown to disappear several weeks after implant-
ation.37,60,61 Hydrogen gas (H2) in particular may
easily diﬀuse into capillaries and be transported by
the vascular system.62 The low degradation rates of
magnesium alloys result in small volumes of generated
gas, but these gas formations are not clinically
visible.52,63,64
Conclusions
The present study investigated a MgYREZr alloy for
use as potential intra-articular degradable implants.
The results of the in vivo study with rabbits showed
no signiﬁcant diﬀerences between the titanium and
the magnesium group. The synovitis was most pro-
nounced after four weeks, and a recovery of the syn-
ovial membrane after 12 weeks in both groups was
observed. It is supposed that the initial inﬂammatory
reaction in the ﬁrst weeks is mainly caused by the sur-
gical trauma. The recovery of the synovial membrane
was more advanced in the titanium group. To evaluate
the cytotoxicity of this novel magnesium alloy, an
in vitro test with L929 and HOB cells was conducted,
in accordance with ISO 10993-5/12. No toxic leachable
compounds were observed after 24 h of incubation. In
conclusion, the MgYREZr alloy seems to be a suitable
material for intra-articular use.
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